Is HRT Covered by Insurance? What Actually Gets Paid For

Short answer: usually yes — if the product is FDA-approved. Most US commercial plans and Medicare Part D cover generic estradiol (oral and patch) and generic micronized progesterone, typically on a low formulary tier. What routinely is not covered: compounded "bioidentical" pellets and creams, a brand when a generic exists, and testosterone for women — because there is no FDA-approved testosterone product for women in the United States. Your plan writes its own formulary, so the honest limit of this page is that we cannot tell you what your plan pays. We can tell you where the line almost always falls, and exactly what to ask.

The line insurers actually draw

Insurers do not decide "is HRT covered" as a category. They decide product by product, using a formulary — a tiered list of drugs the plan pays for. Two facts explain nearly every coverage decision in menopause hormone therapy:

1. FDA approval is the gatekeeper. Compounded drugs are not FDA-approved, so plans generally exclude them outright. This is not the insurer being cruel about "bioidentical" hormones; it is the standard rule applied to every compounded product.
2. A generic kills the brand's coverage. Once a molecule has a generic, the branded version usually moves to a high tier or off the formulary. Estradiol has generics. Micronized progesterone has generics. So the branded versions are frequently the ones getting denied — while the same hormone, generically, sails through.

The prices that make coverage almost irrelevant

Here is the part telehealth ads never mention: for the two workhorse hormones, the cash price is often lower than a bad copay. The figures below are published discount-card cash prices from GoodRx's own price pages, checked in July 2026 — they are not insurance copays, they move constantly, and they vary by pharmacy, strength and coupon. Treat them as a shape, not a quote.

The practical consequence: if your plan denies generic estradiol or parks it on a painful tier, running it as a cash prescription with a discount card is often cheaper than fighting. Warehouse-club and independent pharmacies are frequently cheapest for the same generic — the identical prescription can differ by tens of dollars across the street. The denials genuinely worth appealing are the expensive ones: branded vaginal estrogen, a transdermal product you medically need instead of a pill, a product with no substitute. Our estradiol and progesterone pages carry the same savings checklist a pharmacist would run.

Vaginal estrogen: covered, but maybe not the one you were prescribed

Low-dose vaginal estrogen for genitourinary syndrome of menopause is usually covered in some form. The fight is over which form. Generic estradiol vaginal cream and generic vaginal tablets are widely covered; branded rings and softgel inserts frequently sit on a high tier or off-formulary. A cross-sectional study of 342 Mid-Atlantic insurance plans (2024 plan year, Journal of Sexual Medicine) put numbers on it: the median out-of-pocket cost of tier-1 vaginal estrogen formulations was $0, tier-4 formulations ran a median of $100, and non-formulary formulations a median of $413. Same hormone, same indication — the difference is which box the plan put it in. So if you were handed a $300 brand, ask your prescriber whether a covered generic form is clinically reasonable for you. That question is free.

Prior authorization and step therapy: the two phrases that mean "not yet"

A drug can be on your formulary and still not come out of the pharmacy. Prior authorization (PA) means the plan wants your prescriber to justify it first. Step therapy (ST) means the plan wants you to try a cheaper drug before it pays for the one you were prescribed. Quantity limits (QL) cap how much it will pay for per fill. All three are printed in the formulary document as small letters next to the drug — check before you leave the appointment, because your prescriber can often submit the paperwork the same day instead of after you have been turned away at the counter.

Medicare Part D: different rules, better ceiling

Medicare does not cover outpatient hormone therapy under Part B — it runs through Part D (or the drug benefit inside a Medicare Advantage plan). Three specifics matter in 2026:

• The out-of-pocket cap is $2,100 in 2026 (up from $2,000 in 2025), with a maximum Part D deductible of $615, per CMS's final CY2026 Part D redesign instructions. Once you hit the cap, your plan pays for your covered drugs for the rest of the calendar year. The old "donut hole" coverage gap is gone.
• Manufacturer copay cards cannot be used with Medicare. This is federal law, not a plan quirk — copay assistance from a drug maker counts as a prohibited inducement under the federal anti-kickback statute for people in Medicare or other federal health programs. If a brand's website says "not valid for patients enrolled in Medicare, Medicaid or TRICARE," that is why. Independent patient assistance foundations are a separate route and may still be open to you.
• You have a formal right to a coverage determination. If your Part D plan won't cover a drug, you or your prescriber can request one. CMS requires the plan to decide within 72 hours (standard) or 24 hours (expedited), counted from when it receives your prescriber's supporting statement. If the answer is no, there is a formal appeal ladder above that — redetermination by the plan, then review by an independent entity.

Compounded pellets and creams: why the denial is not a mistake

Compounded hormone pellets and custom creams are almost never covered, and the reason is structural. They are not FDA-approved and carry no FDA-approved label. The National Academies of Sciences, Engineering, and Medicine — reviewing the evidence at the FDA's request — found that the safety and effectiveness data for compounded bioidentical hormone therapy came largely from anecdote, patient reports and prescriber testimony, and recommended that prescribers restrict its use to two situations: allergy to an ingredient in an FDA-approved product, or a dosage form that no approved product offers. Insurers read the same report. Many pellet clinics run on cash for exactly this reason.

We are not telling you to use or avoid compounded hormones — that is between you and a clinician who knows your history. We are telling you not to expect your insurer to pay for them, and to read what "bioidentical" actually means before you sign a payment plan. Note too that FDA-approved estradiol and micronized progesterone are bioidentical — structurally identical to the hormones your body makes — so the word is not the dividing line the marketing implies. See also bioidentical hormone myths.

Testosterone: the honest gap

There is no FDA-approved testosterone product for women in the United States. When it is prescribed for low sexual desire after menopause, it is off-label use of a male formulation at a fraction of the male dose, or a compounded preparation. Both routes are frequently denied, and out-of-pocket costs above $100 a month are common. That is a policy gap, not a judgment about you. Read testosterone therapy for women for what the evidence does and does not support.

The four levers that actually work

1. Ask the prescriber to write the generic. Not "dispense as written." This one line solves most estradiol and progesterone cost problems before they start.
2. Look up the tier before you fill. Your plan's formulary is a searchable PDF or lookup tool on the member portal. Tier 1 versus tier 4 is often the entire difference between $0 and $200.
3. Request a formulary exception when a covered alternative genuinely won't work for you — for example, an oral estrogen is not appropriate for you and you need transdermal. Your prescriber submits a supporting statement; for Part D the plan must decide within the timeframes above, and commercial plans work to their own published deadlines (ask for them in writing). Say what is true about your situation and nothing else. Never let anyone, including a clinic, misstate a diagnosis or a trial-and-failure history to get a drug approved — that is fraud, and it is your name on the claim.
4. Use the manufacturer copay card if you have commercial insurance and there is genuinely no generic. Check eligibility on the manufacturer's own page. These cards generally cannot be used with Medicare, Medicaid or TRICARE.

Run your own numbers with our cost & coverage estimator, and see how much menopause care actually costs for the visit-and-labs side of the bill.

Exactly what to ask your insurer

Call the member services number on your card and ask these, in this order. Write down the reference number for the call and the name of the person you spoke to.

• "Is [drug name and strength] on my formulary, and what tier is it on?"
• "What is my copay for a 30-day and a 90-day supply, at retail and at mail order?"
• "Does it require prior authorization, step therapy, or quantity limits?"
• "If the answer is no — what is the covered alternative in this class?"
• "How does my prescriber file a formulary exception, and what is the decision deadline?"
• "Have I met my deductible? Does the drug benefit have a separate deductible?"

When to talk to your prescriber

Bring cost into the appointment; it is a clinical variable, not a rude question. Talk to your prescriber if a hormone product is unaffordable or was denied — before you skip fills. Do not self-adjust, stretch, split or skip doses to make a prescription last longer, and do not double up after a missed dose. The dose is set by the FDA-approved label and by your prescriber, not by your bill. Also contact a clinician promptly for any vaginal bleeding after menopause, a new severe headache, chest pain, shortness of breath, or leg swelling or pain while on hormone therapy — those are urgent, not billing questions. If you are unhappy with your current care, how to find a menopause specialist and questions to ask your doctor about HRT will get you further than a coupon.

Disclosure: VidaBeacon may earn a commission from some links to care or products on this site. It does not change what we cover, what we recommend, or the prices you pay. We do not accept payment to name a specific telehealth provider or pharmacy here — if you are evaluating one, ask what its total monthly cost includes, whether it bills your insurance or is cash-only, and whether it prescribes FDA-approved products or compounded ones.

Prices and coverage rules in this article were checked in July 2026 and change frequently. Cash prices cited are published discount-card prices, not insurance copays, and they vary by pharmacy, strength and location. This is general information, not medical advice, and not a guarantee of coverage under any plan.